EUVIMEDEUVIMED entdecken
Crossref

Effects of TGF-β2 on cholangiocyte activation and the canonical TGF-β signaling pathway

K. Schorn, S. Hammad, C. De la Torre, M. Ebert, S. Dooley, A. Dropmann

Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e700-e701

DOI: 10.1055/s-0044-1789859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von K. Schorn und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

TGF-β1 is well studied as a key cytokine in liver fibrogenesis. However, the role of the isoform TGF-β2 is less understood. It has been shown that TGF-β2 plays a predominant role in the pathogenesis of biliary cholestatic liver diseases such as PSC and PBC.

Objective

The aim of this project is to investigate the influence of TGF-β2 compared to TGF-β1 on parenchymal liver cells in more detail. Particularly, on the canonical signaling cascade, effects on cell fate and the cell cycle. Methodology: We used human biliary epithelial cells, MMNK, for 2h, 24h and 48h TGFβ1 or TGFβ2 (5 ng/ml), and/or 24h/72h Lipopolysaccharide (LPS) treatment experiments. Protein lysate and mRNA samples were analyzed using immunoblotting and RT-PCR.

Results

In MMNK-1, both 5ng/ml TGF-β1 and 5ng/ml TGF-β2 activate the canonical pSmad3 signaling pathway. Signals are visible after 1h, stronger for TGF-β1 than for TGF-β2. Further, the TGF-β1-induced signal persists longer (figure A and B). Activation of cholangiocytes led to IL-6 expression upregulation via LPS. TGF-β1 and TGF-β2 treatment suppressed this mechanism. In this context, typical cell cycle marker e.g. p21 were also downregulated. RNA sequencing of the cholangiocyte cell line revealed stronger gene regulation upon TGF-β2 treatment in cholangiocytes compared to TGF-β1. Among those are TGF-β regulator genes such as Smad7 or ECM genes. Shared regulated genes after both treatments will be evaluated for their kinetics and a comparison will be done for common or exclusively by TGF-β1 and TGF-β2 treatment regulated genes. Validation of selected targets will be done in alignment to cell fate and behavior data. Fig. 1 Fig. 2 Fig. 3 Fig. 4 Conclusion: Both TGF-β1 and TGF-β2 activate the canonical TGF-β signaling pathway, but TGF-β1 is dominant. There are also indications that both TGF-β isoforms can have inhibitory effects on cholangiocyte activation. This will be further investigated through the p42/44 marker and the interleukin-6 signaling cascade. Additionally, TGF-β1 and TGF-β2 appear to play a repressive role in the senescence behavior of cholangiocyte. Effects of TGF-β2 seem to have stronger impact on cholangiocytes and shedding light on this TGF-β isoform. Further research is currently performed to fully elucidate the underlying mechanisms. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Schorn, K., Hammad, S., Torre, C. D. L., Ebert, M., Dooley, S., & Dropmann, A. (2024). Effects of TGF-β2 on cholangiocyte activation and the canonical TGF-β signaling pathway. Zeitschrift für Gastroenterologie, 62(09), e700-e701. https://doi.org/10.1055/s-0044-1789859

Vancouver

Schorn K, Hammad S, Torre CDL, Ebert M, Dooley S, Dropmann A. Effects of TGF-β2 on cholangiocyte activation and the canonical TGF-β signaling pathway. Zeitschrift für Gastroenterologie. 2024;62(09):e700-e701. doi:10.1055/s-0044-1789859

BibTeX
@article{Schorn2024,
  author = {Schorn, K. and Hammad, S. and Torre, C. De la and Ebert, M. and Dooley, S. and Dropmann, A.},
  title = {Effects of TGF-β2 on cholangiocyte activation and the canonical TGF-β signaling pathway},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {09},
  pages = {e700--e701},
  doi = {10.1055/s-0044-1789859}
}
Kostenlos starten →